Navigation Links
Contract Research Organizations Set to Experience Rapid Growth as Development Costs for New Drugs Continue to Rise
Date:5/15/2012

FARMINGTON, Conn., May 15, 2012 /PRNewswire-iReach/ -- Global Information Inc. is pleased to announce two significant new reports on Drug Development:

Contract Research Organizations Market to 2018
The Contract Research Organizations industry grew at the rate of 12% from 2009 to 2010 according to GBI Research's new market research report, Contract Research Organizations Market to 2018: Public-Private Partnerships to Strengthen Research Capacities and Advance Clinical Development Programs. This April 2012 report provides a comprehensive insight into the size of the CRO market, and includes forecasts, key reasons for outsourcing, technology developments affecting CRO's, public private partnerships, profiles of top CROs, drivers and restraints and deals analysis.

All the companies are looking to cut down the time for launch of drugs along with a reduction in the expenditure on R&D. GBI research estimates that the global R&D outsourcing market in 2010 was 25.3% of the total pharmaceutical R&D expenditure. The expenditure is estimated to increase at the rate of 5% annually and is expected to reach 37.1% of the total R&D expenditure by 2018.

An Executive Summary for this report and a free sample of the full document are available at http://www.giiresearch.com/report/gbi238358-contract-research-organizations-cros-market-2018.html

Outsourcing in Drug Development: The Contract CRO, Clinical Trial Lab and EDC Market
Estimates put the cost of developing and bringing a drug to market at over $1.3 billion. As drug development may take as long as 15 years, major pharmaceutical marketers continue to outsource stages of development, creating growing demand for Contract Research Organizations (CROs). A key cost driver during the expensive clinical trial phase is the large number of failures. Driven by pressures to reduce costs, companies are increasingly implementing outsourcing strategies to increase revenues through faster drug development.

Kalorama Information's new market research report, Outsourcing in Drug Development: The Contract CRO, Clinical Trial Lab and EDC Market, studies the drivers for outsourcing drug development, the companies involved in this market, and the opportunity for revenues. The report offers Market Size and Forecasts for Outsourcing In Drug Development, market drivers and restraints; as well as profiles of CROs, clinical trial laboratories, EDC companies and site management networks.

A summary for this report and a free sample of the full document are available at http://www.giiresearch.com/report/kl225424-outsourcing-drug-development-contract-cro-clinical.html

About Global Information Inc. Global Information (GII) (http://www.giiresearch.com) is an information service company partnering with over 300 research companies around the world. Global Information has been in the business of distributing technical and market research for more than 25 years. Expanded from its original headquarters in Japan, Global Information now has offices in Korea, Taiwan, Singapore, Europe and the United States.

Media Contact: Jeremy Palaia Global Information, Inc., 1-860-674-8796, Press@gii.co.jp

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE Global Information, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Bacterin International Signs Its Third National GPO Contract with Novation
2. Nonin Medical Awarded Novation Contract for Clinically Proven Pulse Oximeters
3. Novation Inks Supplier Contract Category Agreement for Masimo SET® pulse oximetry and rainbow® SET Pulse CO-Oximetry™
4. Biomedical Advanced Research and Development Authority (BARDA) Exercises Option with Pfenex Inc. To Extend Contract for the Development of a Recombinant Protective Antigen (rPA) Based Anthrax Vaccine
5. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
6. QBC Diagnostics Awarded GSA Contract
7. Prime Therapeutics Announces CareCentered Contract™ with EMD Serono, Inc. for MS Drug Rebif®
8. The Centers for Disease Control & Prevention Signs Vaccine Warehouse and Distribution Contract with Sentry BioPharma Services
9. Former Synteract CEO Unveils Non-Profit Contract Research Organization, PHACT, to Help Eliminate Neglected Diseases in Developing Countries
10. European Pharmaceutical and Biotech Contract Manufacturing Markets
11. Unity Management Group Subsidiary Announces First Contracts of 2012 with Purdue Pharma L.P. and Novartis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... New York , March 28, 2017 ... a largely consolidated vendor landscape, with the top three ... Agilent Technologies accounting for a significant 49% of the ... a recent report. The vendor landscape is intensely competitive ... share in the overall market. These factors have restricted ...
(Date:3/28/2017)... and TEL AVIV, Israel , March 28, ... in Israel . This new business entity, Emosis ... mostly dedicated to research and development of novel assays complementing the ... also, when relevant, locally support commercialization and sales development of Emosis ... This strategic ...
(Date:3/28/2017)... 2017  CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a ... and other unmet medical needs, announced today two ... Research annual meeting.  The first poster to be ... of ENMD-2076 in Combination with Anti-PD1 in Syngeneic ... be presented on April 4 is entitled " ...
Breaking Medicine Technology:
(Date:3/28/2017)... ... ... The Radiology Business Management Association (RBMA) is pleased to announce that ... Mr. Still was selected through a careful months-long search by the RBMA Board of ... our members, has been a part of building the RBMA since 1992,” said RBMA ...
(Date:3/28/2017)... ... ... With less than 10,000 dermatologists in the United States and more than ... the desire to conquer breakouts and eliminate skincare stress is widespread. Curology , ... released its inaugural survey on the State of Acne in America. , The ...
(Date:3/28/2017)... ... March 28, 2017 , ... A minimally invasive ... “perfect smile.” The National Association of Dental Laboratories (NADL) is informing dentists about ... aware of when utilizing dental laboratories and technicians that create these veneers. ...
(Date:3/28/2017)... ... March 28, 2017 , ... With expansion and efficiency ... in early March. , The seed processing plant opened in Marshallville in 2006, and ... The new office allows opportunity for transition of Patten Seed operations to the Middle ...
(Date:3/28/2017)... (PRWEB) , ... March 28, 2017 , ... “A Prophets Bones”: a thrilling adventure that ... Donald Quinn. , “There were things that his parents and teachers had asked of him ... way that he was going to defy the Almighty Creator. There were some who would ...
Breaking Medicine News(10 mins):